NL262354A - - Google Patents

Info

Publication number
NL262354A
NL262354A NL262354DA NL262354A NL 262354 A NL262354 A NL 262354A NL 262354D A NL262354D A NL 262354DA NL 262354 A NL262354 A NL 262354A
Authority
NL
Netherlands
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of NL262354A publication Critical patent/NL262354A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NL262354D 1960-03-17 NL262354A (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15549A US3039929A (en) 1960-03-17 1960-03-17 Stable isoproteronol compositions

Publications (1)

Publication Number Publication Date
NL262354A true NL262354A (en:Method)

Family

ID=21772038

Family Applications (1)

Application Number Title Priority Date Filing Date
NL262354D NL262354A (en:Method) 1960-03-17

Country Status (6)

Country Link
US (1) US3039929A (en:Method)
BE (1) BE601304A (en:Method)
BR (1) BR6127708D0 (en:Method)
FR (1) FR1235M (en:Method)
GB (1) GB963264A (en:Method)
NL (1) NL262354A (en:Method)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL289785A (en:Method) * 1962-11-29
US3274057A (en) * 1963-10-30 1966-09-20 Merck & Co Inc Stable hexylresorcinol compositions
IT1212896B (it) * 1983-11-08 1989-11-30 Della Valle Francesco Metodo di somministrazione per via inalatoria di gangliosidi e derivati, e composizioni farmaceutiche relative
US4581225A (en) * 1984-04-25 1986-04-08 Eli Lilly And Company Sustained release intranasal formulation and method of use thereof
US4940728A (en) * 1985-05-17 1990-07-10 Postley John E Treatment for sino-nasal congestion
EP0338670B1 (en) * 1988-03-22 1994-05-11 FISONS plc Pharmaceutical Compositions
EP0935415B1 (en) * 1996-05-01 2006-11-22 Imarx Pharmaceutical Corp. In vitro methods for delivering nucleic acids into a cell

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2350435A (en) * 1942-05-11 1944-06-06 Claude R Wickard Derivatives of ascorbic acid
BE555319A (en:Method) * 1956-03-21 1900-01-01

Also Published As

Publication number Publication date
BR6127708D0 (pt) 1973-07-03
FR1235M (fr) 1962-04-09
US3039929A (en) 1962-06-19
BE601304A (fr) 1961-09-14
GB963264A (en) 1964-07-08

Similar Documents

Publication Publication Date Title
AT229076B (en:Method)
BE601692A (en:Method)
BE601705A (en:Method)
BE462078A (en:Method)
BE586216A (en:Method)
BE586455A (en:Method)
BE587230A (en:Method)
BE587270A (en:Method)
BE589307A (en:Method)
BE590304A (en:Method)
BE592050A (en:Method)
BE592695A (en:Method)
BE592742A (en:Method)
BE592985A (en:Method)
BE593476A (en:Method)
BE593786A (en:Method)
BE593873A (en:Method)
BE594889A (en:Method)
BE594973A (en:Method)
BE594974A (en:Method)
BE595807A (en:Method)
BE597003A (en:Method)
BE597086A (en:Method)
BE597263A (en:Method)
BE598165A (en:Method)